Literature DB >> 1947082

Thyroid gland: US screening in a random adult population.

A Brander1, P Viikinkoski, J Nickels, L Kivisaari.   

Abstract

High-frequency ultrasound examination of the thyroid was performed in 253 subjects (130 women and 123 men; age range, 19-50 years) that were randomly selected from the population in an area of Finland where goiter is not endemic. Thyroid echo abnormalities were detected in 69 subjects (27.3%). Prevalence of abnormalities increased with age, and women showed more lesions than did men in each of the 3 decades. The abnormality was solitary in 39 subjects (57%), multiple in 15 (22%), and diffuse in 15 (22%). Of the 68 individual nodules, 48 (70%) were smaller than 1 cm in diameter. Anechoic rounded nodules 1-5 mm in diameter were found in 28 subjects. Fine-needle aspiration biopsy was performed in 30 subjects. Cytologic examination revealed no unequivocal malignancies. In eight subjects (3.2%) with a diffuse echo abnormality, cytologic evaluation indicated lymphocytic thyroiditis. It is concluded that the prevalence of small thyroid echo abnormalities in a randomly selected adult population is rather high, a fact that supports use of a conservative approach to these types of findings.

Entities:  

Mesh:

Year:  1991        PMID: 1947082     DOI: 10.1148/radiology.181.3.1947082

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  85 in total

1.  Ultrasound-guided percutaneous thyroid nodule core biopsy: clinical utility in patients with prior nondiagnostic fine-needle aspirate.

Authors:  Anthony E Samir; Abhinav Vij; Melanie K Seale; Gaurav Desai; Elkan Halpern; William C Faquin; Sareh Parangi; Peter F Hahn; Gilbert H Daniels
Journal:  Thyroid       Date:  2012-02-03       Impact factor: 6.568

2.  Potential causes for obtaining non-diagnostic results from fine needle aspiration biopsy of thyroid nodules.

Authors:  Deniz Özel; Betül Duran Özel; Fuat Özkan
Journal:  Radiol Med       Date:  2016-02-16       Impact factor: 3.469

3.  Cost-effectiveness of fine-needle-aspiration cytology of thyroid nodules with intranodular vascular pattern using two different needle types.

Authors:  C Cappelli; A Tironi; C Mattanza; D Cumetti; B Agosti; E Gandossi; I Pirola; E De Martino; L Cherubini; L Micheletti; M Castellano; E Agabiti Rosei
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

4.  Qualitative and quantitative evaluation of solitary thyroid nodules with contrast-enhanced ultrasound: initial results.

Authors:  Tommaso Vincenzo Bartolotta; Massimo Midiri; Massimo Galia; Giuseppe Runza; Marco Attard; Giovanni Savoia; Roberto Lagalla; Adelfio Elio Cardinale
Journal:  Eur Radiol       Date:  2006-05-03       Impact factor: 5.315

5.  US, colour-Doppler US and fine-needle aspiration biopsy in the diagnosis of thyroid nodules.

Authors:  F Stacul; M Bertolotto; F De Gobbis; L Calderan; V Cioffi; A Romano; F Zanconati; M A Cova
Journal:  Radiol Med       Date:  2007-07-26       Impact factor: 3.469

6.  Diffusion-weighted MR imaging of thyroid nodules.

Authors:  Zulkif Bozgeyik; Sonay Coskun; A Ferda Dagli; Yusuf Ozkan; Fatih Sahpaz; Erkin Ogur
Journal:  Neuroradiology       Date:  2009-01-23       Impact factor: 2.804

7.  Evaluation and development of a real-time predictive model for ultrasound investigation of malignant thyroid nodules.

Authors:  Po-Wen Cheng; Hsu-Wen Chou; Chi-Te Wang; Wu-Chia Lo; Li-Jen Liao
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-12       Impact factor: 2.503

8.  Thyroid incidentaloma.

Authors:  Seema Singh; Anutosh Singh; A K Khanna
Journal:  Indian J Surg Oncol       Date:  2011-11-23

Review 9.  Pax-8-PPAR-γ fusion protein in thyroid carcinoma.

Authors:  Priyadarshini Raman; Ronald J Koenig
Journal:  Nat Rev Endocrinol       Date:  2014-07-29       Impact factor: 43.330

10.  Thyroid volume in type 1 diabetes patients without overt thyroid disease.

Authors:  G Bianchi; P Montanari; A Fabbri; A Gamberini; M Zoli; G Marchesini
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.